Schedule 13G ownership disclosure
MARINUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 56854Q200
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,390,000
- Percent of class
- 7.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000790
- Form type
- SC 13G
- Filer
- MARINUS PHARMACEUTICALS, INC.
- CIK
- CIK 1267813
- Filed
- Nov 14, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership